These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2572590)

  • 41. alpha 1-Antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exon.
    Nukiwa T; Takahashi H; Brantly M; Courtney M; Crystal RG
    J Biol Chem; 1987 Sep; 262(25):11999-2004. PubMed ID: 3040726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin.
    Law RH; Sofian T; Kan WT; Horvath AJ; Hitchen CR; Langendorf CG; Buckle AM; Whisstock JC; Coughlin PB
    Blood; 2008 Feb; 111(4):2049-52. PubMed ID: 18063751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular cloning and functional expression of rabbit alpha2-antiplasmin.
    Jobse BN; Sutherland JS; Vaz D; Bhakta V; Sheffield WP
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):283-91. PubMed ID: 16651871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A naturally occurring nonpolymerogenic mutant of alpha 1-antitrypsin characterized by prolonged retention in the endoplasmic reticulum.
    Lin L; Schmidt B; Teckman J; Perlmutter DH
    J Biol Chem; 2001 Sep; 276(36):33893-8. PubMed ID: 11427540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Contribution of Japanese researchers to progress in the field of hematology in the last 100 years: Congenital deficiency of alpha2-plasmin inhibitor].
    Kamiya T; Aoki N; Saito H; Kohakura S; Koie K
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2062-5. PubMed ID: 12187678
    [No Abstract]   [Full Text] [Related]  

  • 46. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
    Meyer K; Williams EC
    Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mannose trimming targets mutant alpha(2)-plasmin inhibitor for degradation by the proteasome.
    Chung DH; Ohashi K; Watanabe M; Miyasaka N; Hirosawa S
    J Biol Chem; 2000 Feb; 275(7):4981-7. PubMed ID: 10671537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin.
    Watkins S; Madison J; Davis E; Sakamoto Y; Galliano M; Minchiotti L; Putnam FW
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):5959-63. PubMed ID: 2068071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implications of excessive fibrinolysis and alpha(2)-plasmin inhibitor deficiency in patients with severe head injury.
    Kushimoto S; Yamamoto Y; Shibata Y; Sato H; Koido Y
    Neurosurgery; 2001 Nov; 49(5):1084-9; discussion 1089-90. PubMed ID: 11846901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 5' splice site mutation in fucosidosis.
    Williamson M; Cragg H; Grant J; Kretz K; O'Brien J; Willems PJ; Young E; Winchester B
    J Med Genet; 1993 Mar; 30(3):218-23. PubMed ID: 8097260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural heterogeneity of α2-antiplasmin: functional and clinical consequences.
    Abdul S; Leebeek FW; Rijken DC; Uitte de Willige S
    Blood; 2016 Feb; 127(5):538-45. PubMed ID: 26626994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344-->Ser).
    Moriyama K; Sasaki J; Arakawa F; Takami N; Maeda E; Matsunaga A; Takada Y; Midorikawa K; Yanase T; Yoshino G
    J Lipid Res; 1995 Nov; 36(11):2329-43. PubMed ID: 8656071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.
    Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L
    J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Congenital deficiency of alpha 2-plasmin inhibitor].
    Aoki N
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):999-1002. PubMed ID: 3270919
    [No Abstract]   [Full Text] [Related]  

  • 56. Deletion within the CYP17 gene together with insertion of foreign DNA is the cause of combined complete 17 alpha-hydroxylase/17,20-lyase deficiency in an Italian patient.
    Biason A; Mantero F; Scaroni C; Simpson ER; Waterman MR
    Mol Endocrinol; 1991 Dec; 5(12):2037-45. PubMed ID: 1665206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impaired secretion of the elongated mutant of protein C (protein C-Nagoya). Molecular and cellular basis for hereditary protein C deficiency.
    Yamamoto K; Tanimoto M; Emi N; Matsushita T; Takamatsu J; Saito H
    J Clin Invest; 1992 Dec; 90(6):2439-46. PubMed ID: 1469096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Localization of the human alpha 2-plasmin inhibitor gene (PLI) to 17p13.
    Kato A; Hirosawa S; Toyota S; Nakamura Y; Nishi H; Kimura A; Sasazuki T; Aoki N
    Cytogenet Cell Genet; 1993; 62(4):190-1. PubMed ID: 8440134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alpha 1-antitrypsin-deficient variant Siiyama (Ser53[TCC] to Phe53[TTC]) is prevalent in Japan. Status of alpha 1-antitrypsin deficiency in Japan.
    Seyama K; Nukiwa T; Souma S; Shimizu K; Kira S
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2119-26. PubMed ID: 8520784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of glycosidase inhibitors on the biosynthesis of alpha 2-plasmin inhibitor and antithrombin III in Hep G2 cells.
    Mori K; Wada Y; Mimuro J; Matsuda M; Yoshikuni Y; Kimura K; Sakata Y
    Biochim Biophys Acta; 1994 Jul; 1226(3):300-6. PubMed ID: 8054362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.